Clinical trial

Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to…

NCT00359658 · Hannover Medical School, Other · Completed

Key facts

NCT number NCT00359658
Title Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation
Official title Conversion Study to Optimize Immunosuppressive Regimen by Withdrawal of Steroids, Cyclosporine A Dose Reduction and a Switch to Mycophenolatmofetile for Patients After Heart Transplantation in the Long-Term.
Lead sponsor Hannover Medical School, Other
Collaborators Hoffmann-La Roche Industry
Status Completed
Study type Interventional
Conditions Heart Transplantation
Intervention type Drug
Interventions prednisolon, Mycophenolatmofetile, Cyclosporin A
Enrollment 40
Start date Nov 1, 2004
Primary completion Jun 1, 2008
Completion Jun 1, 2008
First posted Aug 2, 2006
Last update posted Feb 13, 2009
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies